Time To Buy Casi Pharma, HC Wainwright

By: via Benzinga
In a report published Tuesday, HC Wainwright analyst Ching-Yi Lin initiated coverage of CASI Pharmaceuticals Inc (NASDAQ: CASI) with a ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.